In previous studies, as well as with anecdotal evidence, low testosterone (low-T) has been linked to depression and behavior changes in men. Low testosterone is increasingly common, especially in the male population of the United States, and causes multiple health issues for men including erectile dysfunction, low muscle mass, low libido and depression/anxiety. It’s no wonder that along with low testosterone, rates of depression have also been on the rise. Every day, thousands of people are being diagnosed or treated for depression with anti-depressant medications. Could depression sometimes be caused by hormone imbalance? Let’s read into a recent study involving testosterone and a protein called growth factor differentiation-15.
Hormone Imbalance and Depression: Is There a Connection?
Our hormones play a huge role in our health and physiology. We need our hormones to be balanced and at correct concentrations in the bloodstream. Unfortunately, as we age, many hormones become imbalanced and usually are not produced in high enough amounts to support various body processes. This can lead to many adverse symptoms, including depression and even lead to suicide. One of the hormones linked to depression is testosterone.
Testosterone is a sex hormone that is produced in high amounts by men and in much lower amounts by women. Some of the main functions include production of sperm, increasing muscle and causing puberty in boys.
Another biochemical discussed in the following study is a protein called growth differentiation factor-15 (GDF-15). This protein is also called macrophage inhibitory cytokine-1. Elevated levels of this protein are associated with inflammation, cancer and myocardial ischemia (reduced blood flow to the heart). GDF-15 has also been explored as a biomarker for disease prognosis. In the following study, both testosterone and GDF-15 were studied for their correlation with depression and suicide.
Major Depressive Disorder Linked to Low Testosterone
A common mental illness is major depressive disorder (MDD) that affects the daily lives of thousands of people and has become the leading cause of disability worldwide. MDD can cause high healthcare costs and increased financial burdens on patients and their families. Even more worrying is the fact that suicide in patients with MDD is one of the leading causes of death in adolescents worldwide. Yes, teenagers and suicide. This is something that definitely needs to be addressed.
Observations have indicated that around 20% of MDD adolescents consider suicide, more than 15% have actually made plans for a suicide attempt and about 10% attempt suicide annually.
It has been theorized that an inflammatory biomarker for MDD may be the protein GDP-15. MDD may also involve dysregulation of neurotransmitters, dysfunction of the hypothalamic-pituitary-thyroid axis (cause of hormone imbalance) and inflammatory responses. Serum GDF-15 levels are significantly elevated in patients with depression who have also suffered from acute ischemic stroke.
MDD also associated with low testosterone and MDD affects men and women differently. Low testosterone is associated with increased risk of MDD. In addition, testosterone and GDP-15 appear to be linked too. In cancer cells, testosterone directly regulates the expression of GDF-15. Because of this link, it’s theorized that it also exists in depression because low testosterone levels are associated with a greater risk of suicidal behavior in men with MDD. The following study was to focus on this link in depression.
Link Between GDP-15, Testosterone and Depression
In the clinical study discussed, 301 men with MDD who were at least 22 years old participated in the study and were hospitalized in the Department of Psychiatry at Renmin Hospital of Wuhan University from July 2018 to November 2020. The patients had to be diagnosed with MDD and with symptoms of depression for at least 4 weeks before the start of the study in order to be included as subjects.
Basic health information was collected at the beginning including BMI, lifestyle, health factors including smoking, alcohol and anti-depressant use. However, the subjects had to be free of anti-depressants for at least one week prior to the start of the study. Blood samples were taken after admission to the hospital and tested for testosterone, HDL cholesterol, LDL cholesterol, thyroid-stimulating hormone (TSH), triglyceride and other parameters.
Comparisons were made between MDD patients with suicidal ideation (39.87%) and patients without suicidal ideations. The patients with suicidal ideation had significantly higher levels of triglyceride, high-sensitivity C-reactive protein and free thyroxine. They also experienced longer depressive episodes and higher uses of antidepressants. In addition, GDF-15 levels were much higher in the suicidal ideation group (132.49 ng/mL compared to 90.16ng/mL).
Low Testosterone and Suicidal Ideation
Patients were also compared as high and low testosterone groups. Men with high levels of testosterone (314 ng/dL or greater) had an average GDF-15 level of 129.41 ng/mL. This is significantly higher than the low testosterone group who had an average of 95.22 ng/mL. In both testosterone groups, GDF-15 levels were significantly lower in subjects without suicidal ideation than among those with ideation.
However, regardless of testosterone levels, serum GDF-15 levels were higher in patients with suicidal ideations than without. Once more detailed analyses were utilized, the GDF-15 levels were associated with suicidal ideation only in patients who had testosterone levels below the average (314 ng/dL). In fact, each 1 standard deviation increase in GDF-15 levels in the low testosterone patient group was associated with a 1.3 fold increase in risk of suicidal ideation.
In other words, increased GDF-15 levels were closely associated with increased risk of suicide, but this correlation was dependent on testosterone deficiency. The researchers think this could be explained by the fact that low levels of testosterone may have direct effects on central nervous system functions and neuroinflammation, which regulates suicidal ideation. It has recently been realized that testosterone has significant anti-inflammatory effects on the body.
Therefore, there is a close relationship between GDF-15 levels, testosterone and suicidal ideation in men with depression. High levels of GDF-15 may actually be damaging the nervous system, causing inflammation, while testosterone has a protective effect as an anti-inflammatory agent, decreasing the neuroinflammation. This activity of GDF-15 in the brain, developing and progressing the depressive disorder, may depend on testosterone levels, because testosterone regulates expression of GDF-15 in the brain.
This study has taken us one step, or maybe several steps closer, into revealing how and why low testosterone levels can result in severe depression and even suicide in men and young males. It is yet another reason for men to take low testosterone seriously and get their blood levels checked on a regular basis. It’s important for men to have a good relationship with a doctor or endocrinologist who takes this stuff, meaning testosterone and hormone imbalance, seriously, because depression and suicide is not a joke.
Contact our clinic to get your testosterone levels checked as soon as possible!
- It’s True: Men Today Have Less Testosterone Compared to Men a Generation Ago - July 13th, 2021
- BPA Here, BPA There, What’s the Reason for the Scare? - June 29th, 2021
- Testosterone Therapy Could Help Quell Your Asthma Attacks - June 20th, 2021
- Non-Stop Cravings for Protein? Blame it on Your Gut Hormones! - May 21st, 2021
- Breaking News: Testosterone May Be the Answer to Autoimmune Diseases - May 14th, 2021
- Both High and Low Levels of Testosterone Correlate With Cardiovascular Issues in Men - April 14th, 2021
- Your Birthplace Heavily Influences Your Future Testosterone Levels - March 6th, 2021
- Human Growth Hormone May Actually IMPROVE Quadricep Strength After Reconstruction of Torn ACL - June 22nd, 2020
- Hormone Levels in Men - Testosterone Injections - September 9th, 2016
- Testosterone Replacement Therapy - January 19th, 2014
Word Count: 1112